CIK 0001840706 · Accelerated filer<br>Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41 21 694 10 60
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- Open-market buys, last 90 days
- $278,388
- in 2 filings
- Open-market sales, last 90 days
- $1,679,030
- in 28 filings, $1.6M under 10b5-1 plans
Net −$1,400,642. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 34 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-14 | Menu Philippe Chief Medical Officer | Sale | −5,000 | $7.88 | $39K | 208,387 |
| 2026-09-14 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −4,000 | $7.88 | $32K | 552,887 |
| 2026-09-11 | Van Well Daan Chief Legal Officer | Sale 10b5-1 | −6,168 | $7.63 | $47K | 338,884 |
| 2026-09-10 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −8,500 | $7.66 | $65K | 3,435,822 |
| 2026-09-08 | HIBBS KATHY L Director | Sale 10b5-1 | −6,250 | $8.13 | $51K | 96,992 |
| 2026-08-27 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −10,000 | $8.91 | $89K | 556,887 |
| 2026-08-25 | Menu Philippe Chief Medical Officer | Sale 10b5-1 | −5,000 | $8.68 | $43K | 213,387 |
| 2026-08-25 | HIBBS KATHY L Director | Sale 10b5-1 | −6,250 | $8.68 | $54K | 103,242 |
| 2026-08-24 | Verma Abhimanyu Chief Technology Officer | Sale 10b5-1 | −5,000 | $8.80 | $44K | 172,171 |
| 2026-08-21 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −5,408 | $8.40 | $45K | 566,887 |
| 2026-08-20 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −4,592 | $8.41 | $39K | 572,295 |
| 2026-08-19 | Verma Abhimanyu Chief Technology Officer | Sale 10b5-1 | −5,000 | $8.20 | $41K | 177,171 |
| 2026-08-19 | Valente Manuela Chief People Officer | Option exercise 10b5-1 | +10,000 | $3.20 | $32K | 220,450 |
| 2026-08-19 | Valente Manuela Chief People Officer | Sale 10b5-1 | −10,000 | $7.94 | $79K | 210,450 |
| 2026-08-19 | Valente Manuela Chief People Officer | Option exercise · Share Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2026-08-19 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −10,000 | $7.94 | $79K | 576,887 |
| 2026-08-13 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −4,000 | $7.52 | $30K | 586,887 |
| 2026-08-12 | Menu Philippe Chief Medical Officer | Sale 10b5-1 | −5,000 | $7.52 | $38K | 218,387 |
| 2026-08-10 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −8,500 | $7.61 | $65K | 3,444,322 |
| 2026-08-07 | Verma Abhimanyu Chief Technology Officer | Sale 10b5-1 | −5,000 | $7.60 | $38K | 182,171 |
Page 2 of 8 · 157 trades